Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial

Yujian Wu(Shandong Agricultural University), Xu Zhang(Guangzhou Medical University), Ming Li(Qiqihar University), Jianbin Li(Shandong Tumor Hospital), Yanfei Wang, Fengxiang Li(Nankai University), Wei Li(People's Liberation Army 401 Hospital), Lin Hu(Guangzhou Medical University), Ping Huang(Guangzhou Medical University), Jia Yuan(Guangzhou Medical University), Zhouping Wang(Jiangnan University), Xiaofei Xie(Guangzhou Medical University)
American Heart Journal
March 19, 2024
Cited by 7


Related Papers